In Southeast Asia and Africa, counterfeit of anti-malarial drugs have made thousands of people's life in trouble, thus there is a need for new laws and provisions against counterfeiters aroused - said experts.
A group of researchers reported in the PLoS Medicine issue that due to counterfeiters malarial parasites become drug-resistant and even put life in a fatal condition.
Facundo Fernandez, a co-author of the paper and a researcher at the Georgia Institute of Technology, told United Press International.
Drugs like Guilin and Sanofi brands of artesunate, and dihydroartemisinin by Beijing COTEC New Technology Corp have all struck by the counterfeiters - said Fernandez, a co-authors and a researcher at the Georgia Institute of Technology.
Fernandez added the problem grows because all counterfeit drugs are usually cheaper and low-income patients generally opt for it. So Government authorities, health authorities, pharmaceutical manufacturers all have parts to play in reducing counterfeits export and its use.
The order put by the Food and Drug Administration to make tight security against medicinal prescriptions now paves way to reduce the use of counterfeits.
Due to intake of counterfeit containing acetaminophen and artesunate, which labeled as made by Guilin, a 23-year-old man was died in eastern Burma last year.
Thus needs more security alerts and changes on legislation and laws dealing with drug manufacturers - says researchers.